The Association of the British Pharmaceutical Industry (ABPI) has added five new patient organisation figures to its patient advisory council, set up to provide patient pe
Johnson & Johnson’s attempt to draw a line under the ongoing litigation it faces over allegations that its talc products cause cancer has been blocked by an appeals co
Inato has raised $20 million in early-stage financing to support the continued development of its clinical trial marketplace, which connects sponsors with its network of t
Sword Health has extended its range of digital interventions for health conditions with the launch of an artificial intelligence-powered programme that can help predict wh
With the US still battling the opioid epidemic, the most widely-used overdose reversal agent – Emergent BioSolutions’ Narcan – can now be bought over the counter at pharma
Hundreds of NHS patients with an incurable form of cervical cancer will be able to get treatment using a combination regimen based on Merck & Co/MSD’s cancer immunothe